Sale

Nicotine Replacement Therapy Market

Global Nicotine Replacement Therapy Market Size, Growth, Trends, Statistics, Forecast: By Product Type: Patches, Gums, Lozenges, Inhalers, Nasal Spray, Sublingual Tablets; By End User: Hospitals, Specialty Clinics, Homecare, Others; Regional Analysis; Patent Analysis; Grants Analysis; Clinical Trials Analysis; Supplier Landscape; 2024-2032

Global Nicotine Replacement Therapy Market Outlook

The global nicotine replacement therapy market size was valued at USD 3.38 billion in 2023, driven by the growing prevalence of health-related issues associated with cigarette smoking and the development of innovative nicotine gums. The market is anticipated to grow at a CAGR of 9.3% during the forecast period 2024-2032 to reach a value of USD 7.52 billion by 2032.

 

Global Nicotine Replacement Therapy Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Rising Awareness Regarding the Health-Related Issues of Cigarettes Aiding the Market for Nicotine Replacement Therapy

The market for nicotine replacement therapy is being aided by the rising prevalence of health-related issues associated with cigarette smoking. Moreover, the increasing cardiovascular diseases related to nicotine consumption is surging the demand for nicotine replacement therapy. The growing use of nicotine chewing gum as a substitute for oral nicotine activities is driving the market for nicotine replacement therapy. As the awareness regarding the harmful effects of nicotine is increasing the demand for nicotine replacement therapy, the market is witnessing robust growth.

The increasing innovations to develop nicotine gums with enhanced taste is significantly contributing to the growth of the market. The growing use of nicotine gums to regulate and control nicotine intake is propelling the growth of the market. Moreover, the development of nicotine gums with innovative flavours like cinnamon, mint, and fruit, among others, to enhance their sensory appeal is positively impacting the market growth of nicotine replacement therapy.

 

Nicotine Replacement Therapy: Market Segmentation

Nicotine replacement therapy is a treatment that aids people quit the consumption of tobacco and nicotine. The products used in nicotine replacement therapy do not contain harmful toxins found in tobacco. As the sudden halt of nicotine intake leads to withdrawal symptoms, nicotine replacement therapy is used to reduce such symptoms.

 

Global Nicotine Replacement Therapy Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The major products of nicotine replacement therapy are:

  • Nicotine Replacement Therapy (NRT)
  • E-cigarettes
  • Heat-not-burn Tobacco Products

Nicotine replacement therapy (NRT) is further divided into inhalers, gum, transdermal patches, sublingual tablets, and lozenges, among others.

The market can be broadly categorised on the basis of its distribution channels into:

  • Offline
  • Online

The EMR report looks into the regional markets of nicotine replacement therapy like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Nicotine Replacement Therapy Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increasing Use of E-Cigarettes as a Nicotine Replacement Therapy to Drive the Market Growth

As e-cigarettes do not expose smokers to harmful gases, they do not result in health-related issues as compared to traditional cigarettes. This is surging their use as a nicotine replacement therapy, especially in developed countries, which is propelling the growth of the market. In addition, the availability of diverse devices for vaping is providing a personalised smoking experience to cigarette smokers to aid them in quitting, which is significantly contributing to the market for nicotine replacement therapy.

The development of innovative e-cigarettes that meet public health standards is expected to drive the market growth.  The increasing approval of sales and marketing of e-cigarettes by health authorities to reduce the dependency on traditional cigarettes is anticipated to fuel the market growth of the nicotine replacement therapy. For instance, in October 2021, the Food and Drug Administration (FDA) of the United States approved the sale and marketing of the e-cigarettes brand, Vuse, for the first time. Furthermore, the initiation of various research and development (R&D) activities to determine the effectiveness of e-cigarette as a nicotine replacement therapy is projected to propel the market growth in the forecast period.

 

Key Industry Players in the Global Nicotine Replacement Therapy Market

The report presents a detailed analysis of the following key players in the global nicotine replacement therapy market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • AstraZeneca
  • Johnson & Johnson
  • Merck & Co.
  • Cipla
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product Type
  • End User
  • Region
Breakup by Product Type
  • Patches
  • Gums
  • Lozenges
  • Inhalers
  • Nasal Spray
  • Sublingual Tablets
Breakup by End User
  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • AstraZeneca
  • Johnson & Johnson
  • Merck & Co.
  • Cipla
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Global Nicotine Replacement Therapy Market Overview 

    3.1    Nicotine Replacement Therapy Market Historical Value (2017-2023) 
    3.2    Nicotine Replacement Therapy Market Forecast Value (2024-2032)
4    Global Nicotine Replacement Therapy Market Landscape
    4.1    Nicotine Replacement Therapy: Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Nicotine Replacement Therapy: Product Landscape
        4.2.1    Analysis by Product Type
        4.2.2    Analysis by End user
5    Global Nicotine Replacement Therapy Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model
    5.4    Key Demand Indicators 
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends  
    5.7    Value Chain Analysis
6    Global Nicotine Replacement Therapy Market Segmentation
    6.1    Nicotine Replacement Therapy Market by Product Type
        6.1.1    Market Overview    
        6.1.2    Patches
        6.1.3    Gums
        6.1.4    Lozenges 
        6.1.5    Inhalers
        6.1.6    Nasal Spray
        6.1.7    Sublingual Tablets
    6.2    Nicotine Replacement Therapy Market by End User
        6.2.1    Market Overview
        6.2.2    Hospitals
        6.2.3    Specialty Clinics
        6.2.4    Homecare
        6.2.5    Others
    6.3    Nicotine Replacement Therapy Market by Region
        6.3.1    Market Overview
        6.3.2    North America
        6.3.3    Europe 
        6.3.4    Asia Pacific
        6.3.5    Latin America
        6.3.6    Middle East and Africa
7    North America Nicotine Replacement Therapy 
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Nicotine Replacement Therapy 
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Nicotine Replacement Therapy 
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Nicotine Replacement Therapy 
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Nicotine Replacement Therapy 
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Regulatory Framework
    12.1    Regulatory Overview
        12.1.1    US FDA
        12.1.2    EU EMA
        12.1.3    INDIA CDSCO
        12.1.4    JAPAN PMDA
        12.1.5    Others
13    Patent Analysis
    13.1    Analysis by Type of Patent
    13.2    Analysis by Publication year
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Patent Age
    13.5    Analysis by CPC Analysis
    13.6    Analysis by Patent Valuation 
    13.7    Analysis by Key Players
14    Grants Analysis
    14.1    Analysis by year
    14.2    Analysis by Amount Awarded
    14.3    Analysis by Issuing Authority
    14.4    Analysis by Grant Application
    14.5    Analysis by Funding Institute
    14.6    Analysis by NIH Departments
    14.7    Analysis by Recipient Organization 
15    Clinical Trials Analysis
    15.1     Analysis by Trial Registration Year
    15.2    Analysis by Trial Status
    15.3    Analysis by Trial Phase
    15.4    Analysis by Therapeutic Area
    15.5    Analysis by Geography
16    Funding and Investment Analysis
    16.1    Analysis by Funding Instances
    16.2    Analysis by Type of Funding
    16.3    Analysis by Funding Amount
    16.4    Analysis by Leading Players
    16.5    Analysis by Leading Investors
    16.6    Analysis by Geography
17    Partnership and Collaborations Analysis
    17.1    Analysis by Partnership Instances
    17.2    Analysis by Type of Partnership
    17.3    Analysis by Leading Players
    17.4    Analysis by Geography
18    Supplier Landscape
    18.1    Pfizer Inc.
        18.1.1    Financial Analysis
        18.1.2    Product Portfolio
        18.1.3    Demographic Reach and Achievements
        18.1.4    Mergers and Acquisitions
        18.1.5    Certifications
    18.2    GlaxoSmithKline plc 
        18.2.1    Financial Analysis
        18.2.2    Product Portfolio
        18.2.3    Demographic Reach and Achievements
        18.2.4    Mergers and Acquisitions
        18.2.5    Certifications
    18.3    Novartis AG 
        18.3.1    Financial Analysis
        18.3.2    Product Portfolio
        18.3.3    Demographic Reach and Achievements
        18.3.4    Mergers and Acquisitions
        18.3.5    Certifications
    18.4    Mylan N.V. 
        18.4.1    Financial Analysis
        18.4.2    Product Portfolio
        18.4.3    Demographic Reach and Achievements
        18.4.4    Mergers and Acquisitions
        18.4.5    Certifications
    18.5    Teva Pharmaceutical Industries Ltd. 
        18.5.1    Financial Analysis
        18.5.2    Product Portfolio
        18.5.3    Demographic Reach and Achievements
        18.5.4    Mergers and Acquisitions
        18.5.5    Certifications
    18.6    Sanofi
        18.6.1    Financial Analysis
        18.6.2    Product Portfolio
        18.6.3    Demographic Reach and Achievements
        18.6.4    Mergers and Acquisitions
        18.6.5    Certifications
    18.7    AstraZeneca 
        18.7.1    Financial Analysis
        18.7.2    Product Portfolio
        18.7.3    Demographic Reach and Achievements
        18.7.4    Mergers and Acquisitions
        18.7.5    Certifications
    18.8    Johnson & Johnson
        18.8.1    Financial Analysis
        18.8.2    Product Portfolio
        18.8.3    Demographic Reach and Achievements
        18.8.4    Mergers and Acquisitions
        18.8.5    Certifications
    18.9    Merck & Co. 
        18.9.1    Financial Analysis
        18.9.2    Product Portfolio
        18.9.3    Demographic Reach and Achievements
        18.9.4    Mergers and Acquisitions
        18.9.5    Certifications
    18.10    Cipla
        18.10.1    Financial Analysis
        18.10.2    Product Portfolio
        18.10.3    Demographic Reach and Achievements
        18.10.4    Mergers and Acquisitions
        18.10.5    Certifications
19    Nicotine Replacement Therapy - Distribution Model (Additional Insight)
    19.1    Overview 
    19.2    Potential Distributors 
    19.3    Key Parameters for Distribution Partner Assessment 
20    Key Opinion Leaders (KOL) Insights (Additional Insight)
21    Company Competitiveness Analysis (Additional Insight)

    21.1    Very Small Companies
    21.2    Small Companies
    21.3    Mid-Sized Companies
    21.4    Large Companies
    21.5    Very Large Companies
22    Payment Methods (Additional Insight)
    22.1    Government Funded
    22.2    Private Insurance
    22.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The global nicotine replacement therapy market reached a value of USD 3.38 billion in 2023.

The market is anticipated to grow at a CAGR of 9.3% during the forecast period of 2024-2032 to reach a value of USD 7.52 billion by 2032.

The market is being aided by the growing prevalence of health-related issues associated with cigarette smoking and the development of innovative nicotine gums.

The industry is expected to be augmented by the growing use of e-cigarettes, the availability of diverse devices for vaping, and the increasing approvals of e-cigarettes.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major products of nicotine replacement therapy in the industry are nicotine replacement therapy (NRT), e-cigarettes, and heat-not-burn tobacco products.

The significant distribution channels in the market are online and offline.

The major players in the industry are Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, AstraZeneca, Johnson & Johnson, Merck & Co., and Cipla, among others.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER